Adicet Bio, Inc. (ACET)
4.57
-0.57
(-11.09%)
USD |
NASDAQ |
Oct 16, 16:00
4.60
+0.03
(+0.66%)
After-Hours: 20:00
Adicet Bio Price : 4.57 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.14 | 5.14 | 4.57 | 4.57 | 188795.0 |
| Oct 15, 2026 | 4.90 | 5.17 | 4.88 | 5.14 | 155102.0 |
| Oct 14, 2026 | 5.10 | 5.27 | 4.800 | 4.89 | 357871.0 |
| Oct 13, 2026 | 5.53 | 5.53 | 5.10 | 5.11 | 326905.0 |
| Oct 12, 2026 | 5.55 | 5.84 | 5.17 | 5.53 | 145880.0 |
| Oct 09, 2026 | 5.72 | 6.05 | 5.605 | 5.61 | 189827.0 |
| Oct 08, 2026 | 6.16 | 6.17 | 5.550 | 5.74 | 487862.0 |
| Oct 07, 2026 | 6.21 | 6.44 | 6.12 | 6.18 | 214301.0 |
| Oct 06, 2026 | 6.52 | 6.55 | 6.21 | 6.25 | 135721.0 |
| Oct 05, 2026 | 6.53 | 6.69 | 6.28 | 6.47 | 152772.0 |
| Oct 02, 2026 | 6.70 | 6.820 | 6.50 | 6.50 | 164979.0 |
| Oct 01, 2026 | 7.06 | 7.17 | 6.64 | 6.64 | 149042.0 |
| Sep 30, 2026 | 6.80 | 7.280 | 6.71 | 7.14 | 211065.0 |
| Sep 29, 2026 | 6.41 | 7.06 | 6.37 | 6.83 | 668202.0 |
| Sep 28, 2026 | 7.96 | 7.96 | 6.25 | 6.35 | 2.149M |
| Sep 25, 2026 | 8.29 | 9.11 | 8.29 | 9.02 | 638601.0 |
| Sep 24, 2026 | 8.49 | 8.49 | 7.89 | 8.27 | 358549.0 |
| Sep 23, 2026 | 9.12 | 9.311 | 8.42 | 8.49 | 263246.0 |
| Sep 22, 2026 | 9.00 | 9.44 | 8.981 | 9.145 | 87831.00 |
| Sep 21, 2026 | 9.23 | 9.24 | 8.782 | 8.93 | 49789.00 |
| Sep 18, 2026 | 8.96 | 9.405 | 8.76 | 9.18 | 114529.0 |
| Sep 17, 2026 | 9.20 | 9.33 | 8.86 | 9.01 | 130676.0 |
| Sep 16, 2026 | 8.52 | 9.44 | 8.445 | 9.05 | 258211.0 |
| Sep 15, 2026 | 9.70 | 9.70 | 7.905 | 8.505 | 479243.0 |
| Sep 14, 2026 | 9.51 | 9.84 | 9.42 | 9.70 | 124757.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.12 |
| Alnylam Pharmaceuticals, Inc. | 231.83 |
| Anika Therapeutics, Inc. | 19.98 |
| Savara, Inc. | 4.45 |
| Vericel Corp. | 40.13 |
Price Related Metrics
| PEG Ratio | -0.1287 |
| Price to Book Value | 0.3561 |
| Earnings Yield | -252.4% |
| Market Cap | 42.78M |
| PEGY Ratio | -0.1287 |